FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for
WEBMay 24, 2022 · As the first and only approved drug in its class in the U.S., the FDA’s approval of VTAMA cream provides an effective new non-steroidal treatment option for millions of adults living with plaque...
Organon to Acquire Dermavant including its Innovative …
WEB6 days ago · JERSEY CITY, N.J., September 18, 2024--Organon enters agreement to acquire Dermavant including innovative VTAMA (tapinarof) cream, 1%, a novel, non-steroidal topical dermatologic therapy.
Dermavant Announces Positive Results from Phase 4 Open-Label Trial of VTAMA
WEBDec 6, 2023 · VTAMA cream reinforced strong efficacy for the treatment of head and neck plaque psoriasis (PsO), with 88.5% of adult patients (n=23/26) achieving a tPGA Success score of 0 (clear) or 1 (almost clear) and ≥2-grade improvement from baseline at Week 12, the primary endpoint of the study.
New Data from Phase 4 Trial of VTAMA® (tapinarof) Cream, 1
WEBOct 16, 2023 · On May 24, 2022, Dermavant announced the FDA approved VTAMA ® (tapinarof) cream, 1% for the treatment of adult plaque psoriasis. The approval made VTAMA cream the first non-steroidal topical novel chemical entity launched for psoriasis in the U.S. in more than 25 years.
FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for …
WEBMay 24, 2022 · FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years.
VTAMA (Tapinarof) Cream, 1% Shows Efficacy in Patients With ...
WEBOct 20, 2023 · VTAMA (tapinarof) Cream, 1% performed well in intertriginous plaque psoriasis (iPsO), according to new Phase 4 data presented at the 43rd Annual Fall Clinical Dermatology Conference in Las Vegas. This Phase 4 study expands the body of data for VTAMA cream in adult plaque psoriasis.
FDA Approves Non-Steroidal Psoriasis Treatment Called Vtama
WEBJul 22, 2022 · The FDA has approved a new topical once-a-day treatment for plaque psoriasis called Vtama. In clinical trials, 40% of patients had clear or almost clear skin with the drug compared to 6% of those given a placebo cream. Vtama is not a corticosteroid.
Follow us on LinkedIn - Dermavant
WEBApr 29, 2024 · Dermavant has been developing VTAMA cream for the treatment of atopic dermatitis in adults and children 2 years of age and older and released positive topline results from its ADORING 1 and 2 pivotal Phase 3 clinical trials in 1H 2023.
Organon to acquire Dermavant, Vtama cream in definitive …
WEB5 days ago · Organon and Dermavant have entered a definitive agreement in which Organon will acquire Dermavant, according to a press release. Organon is an independent global health care company dedicated to ...
FDA Approves Dermavant's Vtama for Psoriasis
WEBMay 24, 2022 · FDA has approved Vtama® (tapinarof) cream, 1%, an aryl hydrocarbon receptor agonist from Dermavant for the topical treatment of plaque psoriasis in adults. Vtama cream is the first and only FDA-approved steroid-free topical medication in its class.
Skip to content